자궁경부암으로의 진행에 따른vascular endothelial growth factor (VEGF),matrix metalloproteinases (MMPs)의 발현

키워드

참고문헌 (33)

1. Anderson MC, "Cervical crypt involvement by intraepithelial neoplasia", Obstet Gynecol, 55, pp.546~550 (1980)
2. Blohmer JU, "Increased incidence of cervical intraepithelial neoplasia in young women in the mitte district", Acta Cytol, 43, pp.195~200 (1999)
3. Kobayashi A, "Smith-McCune K. Recent developments in understanding the immune response to human papilloma virus infection and cervical neoplasia", Oncol Nurs Forum, 27, pp.643~651 (2000)
4. Barsky SH, "Loss of basement membrane components by invasive tumors but not their benign counterparts", Lab invest, 49, pp.140~147 (1983)
5. Liotta LA, "Tumor invasion and metastasis: An imbalance of positive and negative regulation", Cancer Res, 51(18), pp.5054S~5059S (1991)
6. Senger DR, "Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid", Science, 219, pp.983~985 (1983)
7. Ray JM, "The role of matrix metalloprotease and their inhibitors in tumor invasion, metastasis and angiogenesis", Eur Respir J, 7, pp.2062~2072 (1994)
8. Lyons JG, "Characteristic of 95-kDa matrix metalloproteinase produced by mammary carcinoma cells", Biochemistry, 30, pp.1449~1456 (1991)
9. Nuovo GJ, "Cytopathology of the lower genital tract : an intergrated approach", Williams & Wilkins (1994)
10. Sier CF, "Tissue levels of matrix metalloproteinases MMP-2 and MMP- 9 are related to the overall survival of patients with gastric carcinoma", Br J Cancer, 74, pp.413~417 (1996)
11. Nuovo GJ, "Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DANs and their inhibitors with prognosis in cervical carcinoma", Cancer Res, 55, pp.267~275 (1995)
12. Davidson B, "Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix- clinicopathologic study using immunohistochemistry and mRNA in situ hybridization", Gynecol Oncol, 72, pp.380~386 (1999)
13. Liotta LA, "Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation", Cell, 64, pp.327~336 (1991)
14. Folkman J, "Induction of angiogenesis during the transition from hyperplasia to neoplasia", Nature, 339, pp.58~61 (1989)
15. Folkman J, "What is the evidence that tumors are angiogensis dependents", J Natl Cancer Inst, 82, pp.4~6 (1990)
16. Weidner N, "Intratumoral vascularity as a prognostic factor in cancer of the urogenital tract", Eur J Cancer, 32A, pp.2506~2512 (1996)
17. Brock TA, "Tumor- secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells", Am J Pathol, 138, pp.213~221 (1991)
18. Nagy JA, "Vascular permeability factor", vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis, 2002, pp.196, 1497~1506
19. Ferrer FA, "Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells", J Urol, 57, pp.2329~2333 (1997)
20. Teicher BA, "Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease", Cancer Res, 52, pp.6702~6704 (1992)
21. Gasparini G, "Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are prognostic markers in node-negative breast carcinoma", J Clin Oncol, 12, pp.454~466 (1994)
22. Maeda K, "Tumor angiogenesis as a predictor of recurrence in gastric carcinoma", J Clin Oncol, 13, pp.477~481 (1995)
23. Fontanini G, "Microvessel count predicts metastatic disease and survival in non-small cell lung cancer", J Pathol, 177, pp.57~63 (1995)
24. Jaeger TM, "Tumor angiogenesis correlates with lymph node metastasis in invasive bladder cancer", J Urol, 154, pp.69~71 (1995)
25. Ravazoula P, "Assessment of angiogenesis in human cervical lesions", Anticancer Res, 16(6B), pp.3861~3864 (1996)
26. 박제용, "침윤성 자궁경부암에서 혈관내피세포 성장인자의 발현과 혈관신생", 대한산부인과학회잡지, 48(5), pp.1258~1264 (2005), 대한산부인과학회
27. Tryggvason K, "Type IV collagenases in invasive tumors", Breast Cancer Res Treat, 24, pp.209~218 (1993)
28. Huang CC, "Collagenase in human head and neck tumors and fibroblast in monolayer cultures", Ann Otol Rhinol Laryngol, 95(2), pp.158~161 (1986)
29. Sreenath T, "Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential", Cancer Res, 52, pp.4942~4947 (1992)
30. Powell WC, "Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice", Cancer Res, 53, pp.417~422 (1993)
31. 김성숙, "전립선 암종에서의 금속단백효소 및 효소저해자의 발현", 대한암학회지, 29, pp.445~453 (1991)
32. 정현철, "인체 위암조직에서 새로운 생물학적 치료목표로서 기저막 단백 분해 효소의 발현", 대한암학회지, 27, pp.897~906 (1995)
33. 이명기, "자궁경부종양의 임상병리학적 특성에 따른 VEGF와 PD-ECGF의 발현과 Ki-76의 활성도", 부인종양, 11, pp.290~300 (2000)

관련 논문AI추천